Docteur LAURENCE HALIMI
✨ Profil synthétique
IA · 05/05/2026Le Docteur Laurence Halimi est un rhumatologue hospitalier à Nice, avec une production scientifique notée par un h-index de 9 et 25 publications. Ses recherches portent principalement sur les maladies respiratoires, notamment l'asthme et la maladie pulmonaire obstructive chronique (MPOC). Il s'intéresse également à la qualité de vie et aux essais cliniques.
Expertises présumées
- Maladies respiratoires
- Asthme
- Maladie pulmonaire obstructive chronique (MPOC)
- Essais cliniques
- Qualité de vie
- Recherche en santé respiratoire
- Évaluation des résultats pour les patients (PROMs)
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
9
h articles cités ≥ h fois chacun. Un h de 9 = 9 publications avec 9+ citations.
Citations
280
Publications
26
i10-index
9
Thématiques principales
- Asthma and respiratory diseases ×12
- Respiratory and Cough-Related Research ×6
- Pharmaceutical industry and healthcare ×4
- Chronic Obstructive Pulmonary Disease (COPD) Research ×3
- Ethics in Clinical Research ×3
Affiliations FR : Université de Montpellier · Centre Hospitalier Universitaire de Montpellier
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Larger quality of life gains with asthma support app: a randomised controlled trial
2025ArticleERJ Open Research
Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study
2023ArticleJournal of Clinical Medicine
Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study
2021ArticleERJ Open Research
Will the asthma revolution fostered by biologics also benefit adult ICU patients?
2021ArticleAllergy
Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
2020ArticleBMC Medical Ethics
Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials
2019ArticleClinical Trials
Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension
2018ArticleJournal of Psychosomatic Research
Future treatment for asthma
2016ArticleEuropean Respiratory Review
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
HOPITAL PRIVE GERIATRIQUE LES SOURCES
10 CAMIN RENE PIETRUSCHI, 06105 Nice
☎ 0492154000Hospitalier
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
BMC medical ethics · 2020
Lire l'abstract Crossref ↓
Abstract Background Patient skepticism concerning medical innovations can have major consequences for current public health and may threaten future progress, which greatly relies on clinical research. The primary objective of this study is to determine the variables associated with patient acceptation or refusal to participate in clinical research. Specifically, we sought to evaluate if distrust in pharmaceutical companies and associated psychosocial factors could represent a recruitment bias in clinical trials and thus threaten the applicability of their results. Methods This prospective, multicenter survey consisted in the administration of a self-questionnaire to patients during a pulmonology consultation. The 1025 questionnaires distributed collected demographics, socio-professional and basic health literacy characteristics. Patients were asked to rank their level of trust for pharmaceutical companies and indicate their willingness to participate in different categories of research (pre or post marketing, sponsored by an academic institution or pharmaceutical company). Logistic regression was used to determine factors contributing to “trust” versus “distrust” group membership and willingness to participate in each category of research. Results One thousand patients completed the survey, corresponding to a response rate of 97.5%. Data from 838 patients were analyzed in this study. 48.3% of respondents declared that they trusted pharmaceutical companies, while 35.5% declared distrust. Being female (p = 0.042), inactive in the employment market(p = 0.007), and not-knowing the name of one’s disease(p = 0.010) are factors related to declared distrust. Distrust-group membership is associated with unwillingness to participate in certain categories of trials such as pre-marketing and industry-sponsored trials. Conclusion Distrust in pharmaceutical companies is associated with a specific patient profile and with refusal to participate in certain subcategories of trials. This potential recruitment bias may explain the under-representation of certain categories of patients such as women in pre-marketing drug trials.
- 2Interference of psychological factors in difficult-to-control asthma
Respiratory medicine · 2007
- 3Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension
Journal of psychosomatic research · 2018
📚 22 citations🎯 RCR 1.16🔓 Open Access
Publications scientifiques (12) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal8
▼
Transversal8
▼- Mid-Term Sequelae of Surviving Patients Hospitalized in Intensive Care Unit for COVID-19 Infection: The REHCOVER Study
Journal of clinical medicine · 2023 · Journal Article
Berger M, Daubin D, Charriot J, Klouche K, et al.
📚 4 cit. - Will the asthma revolution fostered by biologics also benefit adult ICU patients?
Allergy · 2021 · Journal Article
Bourdin A, Charriot J, Boissin C, Ahmed E, et al.
📚 7 cit. - Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
BMC medical ethics · 2020 · Journal Article
Pahus L, Suehs CM, Halimi L, Bourdin A, et al.
📚 28 cit.🎯 RCR 1.59🔬→🩺 Translationnel - Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials
Clinical trials (London, England) · 2019 · Letter
Molinari N, Suehs C, Vachier I, Pahus L, et al.
📚 1 cit. - Severe asthma and adherence to peak flow monitoring: longitudinal assessment of psychological aspects
Journal of psychosomatic research · 2010 · Journal Article
Halimi L, Pry R, Pithon G, Godard P, et al.
📚 14 cit.🔬→🩺 Translationnel - [Treatment education for patients with asthma]
Presse medicale (Paris, France : 1983) · 2009 · English Abstract
Halimi L, Bourdin A, Mahjoub BA, Godard P
📚 5 cit. - Interference of psychological factors in difficult-to-control asthma
Respiratory medicine · 2007 · Journal Article
Halimi L, Vachier I, Varrin M, Godard P, et al.
📚 28 cit.🎯 RCR 1.07 - [Difficult asthma]
Presse medicale (Paris, France : 1983) · 2006 · English Abstract
Chanez P, Vachier I, Bourdin A, Halimi L, et al.
📚 6 cit.
Qualité de vie / PROMs2
▼
Qualité de vie / PROMs2
▼- Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study
ERJ open research · 2021 · Journal Article
Halimi L, Suehs CM, Marin G, Boissin C, et al.
📚 11 cit. - Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension
Journal of psychosomatic research · 2018 · Journal Article
Halimi L, Marin G, Molinari N, Gamez AS, et al.
📚 22 cit.🎯 RCR 1.16🔬→🩺 Translationnel
Essai clinique1
▼
Essai clinique1
▼- Larger quality-of-life gains with an asthma support app: a randomised controlled trial
ERJ open research · 2025 · Journal Article
Bourdin A, Casanova S, Ahmed E, Brouard B, et al.
Revue générale1
▼
Revue générale1
▼- Future treatment for asthma
European respiratory review : an official journal of the European Respiratory Society · 2016 · Journal Article
Charriot J, Vachier I, Halimi L, Gamez AS, et al.
📚 15 cit.🔬→🩺 Translationnel
Datasets & protocoles partagés
Additional file 1 of Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
Dataset2020figshareAdditional file 1. Questionnaire PROTOACCEPT - French/English bilingual version.
Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
Collection2020figshareAbstract Background Patient skepticism concerning medical innovations can have major consequences for current public health and may threaten future progress, which greatly relies on clinical research. The primary objecti
Additional file 1 of Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
Dataset2020figshareAdditional file 1. Questionnaire PROTOACCEPT - French/English bilingual version.
Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
Collection2020figshareAbstract Background Patient skepticism concerning medical innovations can have major consequences for current public health and may threaten future progress, which greatly relies on clinical research. The primary objecti
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
